Related Experiment Videos
Interleukin-18 and Crohn's disease.
T Kanai1, M Watanabe, A Okazawa
1Keio Cancer Center, School of Medicine, Keio University, Keio, Japan.
Digestion
|February 15, 2001
Summary
Interleukin-18 (IL-18) plays a key role in regulating intestinal inflammation in Crohn's disease (CD). This study investigated IL-18's function in controlling mucosal lymphocytes within the inflamed gut.
Area of Science:
- Immunology
- Gastroenterology
- Cytokine Biology
Background:
- Inflammatory bowel disease (IBD), including Crohn's disease (CD), involves complex immune dysregulation in the gut.
- Activated Th1 CD4+ T cells and macrophages accumulate in the inflamed intestinal mucosa of CD patients.
- Interleukin-18 (IL-18), a cytokine primarily found in macrophages, influences Th1 cell development and interferon-gamma production, similar to IL-12.
Purpose of the Study:
- To elucidate the specific role of IL-18 in the pathogenesis of intestinal inflammation in Crohn's disease.
- To investigate how IL-18 regulates intestinal mucosal lymphocytes in both human CD and a murine model of CD.
Main Methods:
- Assessment of IL-18's functional impact on intestinal mucosal lymphocytes.
- Utilizing a human CD cohort and a murine CD model for comparative analysis.
Main Results:
- The study evaluated the functional significance of IL-18 in modulating the immune response within the intestinal mucosa.
- Results demonstrated IL-18's involvement in the immune cell dynamics characteristic of Crohn's disease.
Conclusions:
- IL-18 is implicated as a significant factor in the immune mechanisms underlying intestinal inflammation in Crohn's disease.
- Further understanding of IL-18's function may offer new therapeutic targets for managing CD.